Showing results (161-170 of 206) with videos related to
Sort By:
Pageof 21
World Journal of Surgical Oncology|March 23, 2016
Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracilYan-Ye Su, Chih-Yen Chien, Sheng-Dean Luo, et al.Molecular Cancer|April 19, 2015
Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancerChang-Han Chen, Alice Y W Chang, Shau-Hsuan Li, et al.Cancers|March 10, 2022
Radiotherapy Is Associated with an Accelerated Risk of Carotid Atherosclerosis in Patients with Nasopharyngeal Carcinoma: A Nine-Year Prospective Follow-Up StudyCheng-Hsien Lu, Yun-Ru Lai, Fu-Min Fang, et al.Radiation Oncology (London, England)|March 21, 2018
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapyYun-Hsuan Lin, Tai-Lin Huang, Chih-Yen Chien, et al.Journal for Immunotherapy of Cancer|July 7, 2026
Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinomaYu-Li Su, Shih-Yu Huang, Chung-Wen Kuo, et al.Head & Neck|April 29, 2015
Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracilShau-Hsuan Li, Wei-Che Lin, Tai-Lin Huang, et al.Biomedical Journal|April 12, 2023
Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancerLichieh Julie Chu, Ya-Ting Chang, Chih-Yen Chien, et al.Analytica Chimica Acta|January 29, 2020
An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samplesYung-Chin Hsiao, Shih-Yu Lin, Kun-Yi Chien, et al.Cellular and Molecular Life Sciences : CMLS|February 21, 2026
ALDH2 inhibits head and neck tumorigenesis through RAS signaling suppression, transactivation of TGM2, and synergy with ALDH6A1Uyanahewa Gamage Shashini Janesha, Chang-Ta Chiu, Ming-Hsien Tsai, et al.Pathology Oncology Research : POR|April 7, 2025
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the IT-MATTERS studyEyal Talor, József Tímár, Philip Lavin, et al.Pageof 21